Zenith Healthcare Ltd
BSE:530665
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zenith Healthcare Ltd
Cash from Operating Activities
Zenith Healthcare Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zenith Healthcare Ltd
BSE:530665
|
Cash from Operating Activities
₹6.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Operating Activities
₹58.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Operating Activities
₹42.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Operating Activities
₹127.2B
|
CAGR 3-Years
46%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Cash from Operating Activities
₹47.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
146%
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash from Operating Activities
₹19.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Zenith Healthcare Ltd
Glance View
Zenith Healthcare Ltd. engages in the manufacture of pharmaceuticals formulation in the forms of tablets, capsules, oral liquids and injections. The company is headquartered in Ahmedabad, Gujarat. The firm offers its products across various therapeutic segments, including antibiotics and anti-infective, gastrointestinal tract, analgesic/anti-inflammatory, cardiovascular system, respiratory, ophthalmology, bio-technical products, oncology, anti-retroviral, central nervous system, nutrition, genito urinary system and skin. Its products across antibiotics and anti-infective category includes Roxythromycin Tablets, Ciprofloxacin Tablets, Azithromycine Dihydrate Suspension and Azithromycin Oral Suspension. Its product across gastrointestinal category includes Ranitidine Hydrochloride Tablets. Its product across cardiovascular system includes Lisinopril Tablets. Its products across analgesic category include Paracetamol and Aceclofenac Tablets. The company offers contract manufacturing of all dosage forms.
See Also
What is Zenith Healthcare Ltd's Cash from Operating Activities?
Cash from Operating Activities
6.7m
INR
Based on the financial report for Mar 31, 2025, Zenith Healthcare Ltd's Cash from Operating Activities amounts to 6.7m INR.
What is Zenith Healthcare Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-19%
Over the last year, the Cash from Operating Activities growth was -61%. The average annual Cash from Operating Activities growth rates for Zenith Healthcare Ltd have been -20% over the past three years , -19% over the past five years .
